Advanced Medical Solutions Group (LON:AMS) Stock Price Passes Above 200-Day Moving Average – Should You Sell?

Advanced Medical Solutions Group plc (LON:AMS)’s share price crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 216.22 and traded as high as GBX 256. Advanced Medical Solutions Group shares last traded at GBX 256, with a volume of 1,924,334 shares.

Analyst Ratings Changes

AMS has been the subject of several recent research reports. Royal Bank Of Canada reissued a “sector perform” rating and set a GBX 260 price target on shares of Advanced Medical Solutions Group in a research report on Thursday, April 9th. Berenberg Bank reaffirmed a “buy” rating and issued a GBX 300 price objective on shares of Advanced Medical Solutions Group in a research report on Wednesday, March 18th. Three analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat, Advanced Medical Solutions Group has an average rating of “Moderate Buy” and a consensus target price of GBX 270.25.

Advanced Medical Solutions Group Stock Performance

The firm has a market cap of £555.87 million, a PE ratio of 56.70, a P/E/G ratio of 5.00 and a beta of 0.72. The company has a debt-to-equity ratio of 31.50, a current ratio of 2.79 and a quick ratio of 4.58. The stock has a 50-day moving average price of GBX 218.60 and a 200 day moving average price of GBX 216.50.

Advanced Medical Solutions Group (LON:AMS) last issued its earnings results on Wednesday, March 18th. The company reported GBX 11.98 earnings per share for the quarter. Advanced Medical Solutions Group had a return on equity of 3.87% and a net margin of 4.35%. Research analysts forecast that Advanced Medical Solutions Group plc will post 9.8159509 earnings per share for the current year.

Advanced Medical Solutions Group Company Profile

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®. AMS also supplies wound care dressings such as silver alginates, alginates and foams through its ActivHeal® brand as well as under white label.